MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
DWTX — Dogwood Therapeutics, Inc. Common Stock
NasdaqDogwood Therapeutics, Inc. Common Stock
$1.46
+0.03(+2.10%)
- O
- 1.45
- H
- 1.56
- L
- 1.43
- V
- 70.92K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About DWTX
Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateDec 17, 2020
Employees8
Stock ExchangeNasdaq
Ticker SymbolDWTX
Websitehttps://www.virios.com
Key Financial Statistics
| Market Cap | $49.63M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.28 - $7.20 |
| 52-Week Avg Volume | 71.5K |
| VWAP | $1.49 |
| Transactions | 1,885 |
| Total Recorded Bars | 1,454 days |